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OBJECTIVE — To test the Mayo Clinic Quadratic (MCQ) equation against isotopic glomer-
ular ﬁltration rate, compared with the Modiﬁcation of Diet in Renal Disease (MDRD) and the
Cockcroft-Gault formulas, in type 2 diabetes.
RESEARCH DESIGN AND METHODS — Based on values obtained with iothalamate,
118 type 2 diabetic patients were divided into three groups according to renal function: hyper-
ﬁltration(26),normalfunction(56),orchronickidneydisease(CKD)stages3–4(36).ANOVA,
the Bland-Altman procedure, and Lins coefﬁcient (Rc) were performed to study accuracy.
RESULTS — In the hyperﬁltration and normal function groups, all prediction equations
signiﬁcantly underestimated the value obtained with isotopic glomerular ﬁltration rate (P 
0.05). In the CKD group, all equations also presented signiﬁcant differences with the isotopic
method. However, MDRD had a bias of 5.3 (Rc 0.452), Cockcroft-Gault formula 0.2 (Rc
0.471), and the MCQ 4.5 (Rc 0.526).
CONCLUSIONS — The MCQ and prediction equations proved inaccurate (excessive un-
derestimation) in type 2 diabetic patients with hyperﬁltration or normal renal function. With
regard to CKD, the results obtained provided no evidence of superiority of the MCQ over the
MDRD or the Cockcroft-Gault formula.
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A
ccording to current epidemiologic
data, type 2 diabetes is considered
one of the most frequent causes of
end-stage chronic renal disease and in-
clusion in renal substitution programs
(1,2). In a previous study, our group
evaluated the accuracy of different pre-
diction equations for the ambulatory
follow-up of a cohort of type 2 diabetic
patients (3). From the results obtained,
it can be concluded that the application
of these equations is inadequate in situ-
ations of normal renal function and hy-
perﬁltration. Recently, the Mayo Clinic
group has developed a new Mayo Clinic
Quadratic (MCQ) equation based on
the results of both healthy subjects (n 
580), who had an iothalamate clearance
test speciﬁcally for kidney donor evalu-
ation, and patients with chronic kidney
disease (CKD) (n  320) (4). However,
only 13% of 320 patients with CKD
were diabetic, and the validity of the
MCQ for patients outside the Mayo
Clinic has been questioned (5).
The aim of the present study was to
test the MCQ against isotopic glomerular
ﬁltration rate (GFR), compared with the
recommended MDRD and Cockcroft-
Gaultformulas,intype2diabeticpatients
with a wide range of GFR (15–209
ml/min per 1.73 m
2)—particularly in
those with hyperﬁltration or normal re-
nal function.
RESEARCH DESIGN AND
METHODS— The study was con-
ducted in 118 Caucasian type 2 diabetic
patients (63 women; mean  SD age
57.2  9.7 years and A1C 7.3  2%).
Accordingtothevaluesobtainedwithiso-
topic GFR, patients were divided into
three study subgroups: hyperﬁltration
(GFR 140 ml/min per 1.73 m
2,2 6p a -
tients); normal renal function (GFR 90–
140 ml/min per 1.73 m
2, 56 patients);
and CKD stages 3–4 (GFR 15–59 ml/min
per 1.73 m
2, 36 patients).
Isotopic GFR was measured by a
single-shot clearance technique using
an intravenous injection of 30–50 Ci
125I-iothalamatecorrectedforbodysur-
face area of 1.73 m
2 (6). In each study
subgroup, the isotopic GFR was com-
paredwiththoseofthefollowingprediction
equations: MDRD (7), Cockcroft-Gault (8),
and MCQ (4). The equation for MCQ cal-
culation is as follows:
exp [1.911  5.249/SCr (mg/dl)
 2.114/SCr
2  0.00686  age
 0.205 if female]
where exp is exponent and SCr is serum
creatinine. All serum creatinine measure-
ments were performed in the same labo-
ratory and determined by the Jaffe ´
alkaline picrate method (normal range
0.6–1.5mg/dl),calibratedusingtheSET-
point Calibrator T13-1291 (Bayer, Barce-
lona, Spain).
Statistical analysis
ANOVA was used to determine signiﬁ-
cant differences (P  0.05 with Bonfer-
roniadjustedforthreecontrasttests).The
Bland-Altman procedure (9,10) (Fig. 1)
andLinscoefﬁcient(Rc)(11)wereusedto
study accuracy. SAS software (version
9.1;SASInstitute,Cary,NC)wasusedfor
statistical analysis.
RESULTS— Mean
125I-iothalamate
GFR was 96.3  50.9 ml/min per 1.73
m
2. In the hyperﬁltration group (aged
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women), mean isotopic GFR was
159.5  18.8 ml/min per 1.73 m
2 and
SCr 79.3  21.7 mol/l. In this group,
the prediction equations that included
MCQ were inaccurate compared with
isotopic GFR and differed statistically
and signiﬁcantly (P  0.05). Bias ob-
tained with the MDRD was 83.1 ml/
min per 1.73 m
2 (Rc 0.034), with the
Cockcroft-Gaultformula62.0ml/min
per 1.73 m
2 (Rc 0.015) and the MCQ
equation50.9ml/minper1.73m
2(Rc
0.045).
In the normal renal function group
(56  8.2 years [range 31–69]; 37
women),meanisotopicGFRwas115.6
14.1 ml/min per 1.73 m
2 and SCr 88.7 
14.8 mol/l. In this group, all prediction
equations and MCQ were inaccurate
compared with the isotopic GFR and dif-
fered statistically and signiﬁcantly (P 
0.05). Bias obtained with the MDRD was
46.5 ml/min per 1.73 m
2 (Rc 0.025),
with the Cockcroft-Gault formula 41.4
ml/min per 1.73 m
2 (Rc 0.013) and the
MCQ equation 23.2 ml/min per 1.73
m
2 (Rc 0.040).
In the CKD stages 3–4 group
(64.1  8.0 years [range 45–84]; 13
Fig. 1
MCQ equation in type 2 diabetic patients
2266 DIABETES CARE, VOLUME 31, NUMBER 12, DECEMBER 2008women), mean isotopic GFR was
31.2  10.8 ml/min per 1.73 m
2 and
SCr 249.0  91.5 mol/l. In this group,
the prediction equations and MCQ also
presented signiﬁcant differences com-
pared with isotopic GFR (P  0.05).
However, bias obtained with the MDRD
was5.3ml/minper1.73m
2(Rc0.452),
with the Cockcroft-Gault formula 0.2
ml/min per 1.73 m
2 (Rc 0.471) and the
MCQ equation 4.5 ml/min per 1.73 m
2
(Rc 0.526).
CONCLUSIONS — According to our
results, the application of these equations
is inadequate in situations of hyperﬁltra-
tion and normal renal function. In the
CKD stages 3–4 group, the results ob-
tained presented no evidence of superior-
ity of the MCQ equation over the MDRD
equation and Cockcroft-Gault formula.
The validity of GFR predictive equations
must be veriﬁed in the diabetic popula-
tion,asbothequations(MDRDandCock-
croft-Gault) were developed from the
results of nondiabetic subjects with CKD.
Despite yielding statistically signiﬁ-
cant differences, in hyperﬁltration and
normal renal function situations, MCQ
presents a mean  SD closer to those of
the isotopic method and lower bias and
CIs in the estimation of renal function. In
this respect, a recent study (12) con-
cluded that the MDRD equation results in
considerably higher rates of estimated
GFR for CKD classes 2 and 3 compared
with the MCQ equation, whereas MDRD
and MCQ were comparable in CKD
classes 4 and 5. In patients with normal
Scr, the MDRD equation underestimated
the iothalamate GFR; thus, its limitation
in clinical practice may give rise to a mis-
classiﬁcation of renal function stage. In
contrasttoRigalleauetal.(13),webelieve
the MCQ equation offers no advantage
over conventional prediction equations
because it excessively underestimates
GFR (high bias and low precision).
As in previous studies (14,3), we
showedthehyperﬁltrationsituation,with
a greater slope for GFR compared with
normal ﬁlters, to be a marker of poor evo-
lution and worse renal function deterio-
ration in type 2 diabetic patients. In these
situations that limit the use of prediction
equations, new markers of renal function
are required. In this respect, one recent
study (15) recommended the use of se-
rumcystatinC(100/cystatinC,expressed
as milligrams per liter) to diagnose early
renal function decline and develop inter-
ventions for protecting renal function
while it is normal or even elevated.
In conclusion, our results showed the
MCQ and conventional prediction equa-
tions to be inaccurate (excessive underes-
timation) in type 2 diabetic patients with
hyperﬁltration or normal renal function.
In CKD stages 3–4, the results obtained
presented no evidence of superiority of
the MCQ equation over the MDRD equa-
tion or Cockcroft-Gault formula.
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